Oncorus

+$0.22 (+2.17%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oncorus and other ETFs, options, and stocks.

About ONCR

Oncorus, Inc. engages in the research and development of viral immunotherapies platform. It develops immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform.

CEO
Theodore T. Ashburn
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2015

ONCR Key Statistics

Market Cap
277.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
113.35K
High Today
$10.39
Low Today
$9.77
Open Price
$10.27
Volume
47.39K
52 Week High
$37.86
52 Week Low
$8.75

ONCR Earnings

-$21.73
-$14.49
-$7.24
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure